Halbert Hargrove Global Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-42
Closed -$2.62K – 638
2025
Q3
$2.62K Buy
+42
New +$2.92K ﹤0.01% 515

Other funds holding PBH

Halbert Hargrove Global Advisors's PBH Position: Q4 2025 in Review

Halbert Hargrove Global Advisors sold out of Prestige Consumer Healthcare (PBH) in Q4 2025, closing a stake of 42 shares — an estimated $2.62K sold.

Halbert Hargrove Global Advisors first reported a position in PBH in Q3 2025 and held it in 1 quarter. The position peaked at $2.62K in Q3 2025. 354 funds tracked by Wall St. Rank hold PBH as of Q4 2025.

  • Halbert Hargrove Global Advisors reported no remaining Prestige Consumer Healthcare position as of Q4 2025 after selling out during the quarter.
  • Halbert Hargrove Global Advisors sold 42 Prestige Consumer Healthcare shares in Q4 2025, an estimated $2.62K.
  • Halbert Hargrove Global Advisors first reported a position in Prestige Consumer Healthcare in Q3 2025 and held it in 1 quarter.
  • Halbert Hargrove Global Advisors's Prestige Consumer Healthcare position peaked at $2.62K in Q3 2025.
  • 354 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2025.

Based on Halbert Hargrove Global Advisors's 13F filing for Q4 2025, filed 23 Jan 2026.